PHI with Turbinate reduction
How does this condition affect your private health insurance?
Verkleinerung der Nasenmuscheln, or turbinate reduction, is a common surgical procedure aimed at alleviating chronic nasal obstruction caused by enlarged inferior turbinates. These structures, responsible for warming and humidifying inhaled air, can swell due to allergies, chronic rhinitis, or anatomical variations, leading to significant breathing difficulties. The procedure typically involves reducing the turbinate tissue, often using methods like radiofrequency ablation, microdebrider resection, or partial turbinoplasty, to create more space for airflow. It is usually performed under local or general anesthesia and is highly effective in improving nasal patency, thereby enhancing the patient's quality of life.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Chronic, often several months to years prior to intervention, representing the duration of the underlying hypertrophy and symptoms.
Duration of Illness (Lifetime)
Chronic condition, often requiring one or more interventions; symptoms may recur, necessitating further management.
Cost of Treatment (Initial)
Approximately €1,000 - €3,000 (outpatient procedure) or €3,000 - €7,000 (inpatient, depending on associated procedures and healthcare system).
Cost of Treatment (Lifetime)
Similar to first occurrence if recurrence requires repeat intervention; otherwise, minimal follow-up costs are expected.
Mortality Rate
Extremely low (<0.01%), typically related to severe anesthesia complications rather than the procedure itself.
Risk of Secondary Damages
Low (5-15%). Potential risks include epistaxis (bleeding), infection, synechiae (scarring), temporary dryness, crusting, or, rarely, 'empty nose syndrome'.
Probability of Full Recovery
High (70-90%) for significant symptomatic improvement and improved nasal breathing; however, complete anatomical 'recovery' to a pristine state is not the goal, but functional success is common.
Underlying Disease Risk
High (60-80%). Often associated with chronic allergic or non-allergic rhinitis, nasal septum deviation, or chronic sinusitis.